Talzenna .5 mg/1 (Talazoparib CAPSULE, LIQUID FILLED) .5 mg/1

Talzenna .5 mg/1 is a medication containing talazoparib, used for targeted therapy in certain cancer treatments. This liquid-filled capsule is designed for oral administration and is manufactured by Pfizer Laboratories.

Strength

.5 mg/1

Pack Size

30 CAPSULE, LIQUID FILLED in 1 BOTTLE (0069-0546-30)

Manufacturer / TM Owner

Pfizer Laboratories Div Pfizer Inc

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Talzenna .5 mg/1 is primarily used in the treatment of specific types of cancer. It works by targeting certain proteins involved in cancer cell growth and repair. Patients often wonder, 'What is Talzenna used for?' This medication is typically prescribed for conditions where DNA damage repair is impaired, helping to slow or stop the progression of cancer cells.

Side Effects

Common effects of Talzenna .5 mg/1 may include fatigue, nausea, and anemia. Some users also report hair loss and changes in taste. These effects can vary from person to person, and it's important to discuss any concerns with a healthcare provider.

Precautions & Warnings

Talzenna .5 mg/1 should be handled with care, following the prescribed dosage and administration guidelines. It is essential to store the medication properly and to inform healthcare providers about any other medications being taken to avoid potential interactions. Pregnant women or those planning to become pregnant should consult their healthcare provider before using this medication.

Avoid Interactions

Talzenna .5 mg/1 may interact with certain medications, including those that affect liver enzymes. It is important to discuss all current medications with a healthcare provider to ensure safe use. Alcohol and other substances that affect liver function should be avoided unless approved by a healthcare professional.

Frequently Asked Questions

Talzenna is used in the treatment of certain types of cancer, particularly those involving DNA damage repair mechanisms.

Talzenna .5 mg/1 is taken orally, typically as directed by a healthcare provider.

Common side effects may include fatigue, nausea, anemia, hair loss, and changes in taste.

It is important to discuss all current medications with a healthcare provider to avoid potential interactions.

Pregnant women or those planning to become pregnant should consult their healthcare provider before using Talzenna.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.